News & Trends - Pharmaceuticals

Pharmacists’ remuneration for COVID-19 vaccinations must be addressed, says PSA

Health Industry Hub | December 14, 2021 |
[Total: 2    Average: 4.5/5]

Pharma News: The Pharmaceutical Society of Australia (PSA) is calling on Federal Government to equally remunerate pharmacists for their involvement in the national vaccination strategy.

As present, pharmacists are receiving $16 per booster vaccine administered, whilst other providers such as general practitioners can receive up to $63.55 – an unfair disparity for providing the same service.

PSA National President, A/Prof Chris Freeman, stressed that the current remuneration model for COVID-19 vaccinations simply isn’t sustainable.

“On Monday [last week], paediatric vaccinations were approved by the TGA, opening up vaccination eligibility to 2.3 million Australian children. This means that extra consultation time will be required to undertake appropriate assessment and consenting, placing further strain on service sustainability.

“As mass vaccination hubs continue to downscale operations over the coming months and we revert to pre-pandemic primary health arrangements, responsibility will fall back on immunisation providers to cover both the 5-11s cohort as well as those eligible for their booster dose.

“Frustration is mounting within the profession. Our pharmacists have had enough and can no longer justify running this service at a loss.

“If the disparity isn’t addressed soon, I am worried we’ll see pharmacies withdrawing their involvement in the national strategy, causing further setbacks in 2022.

“If pharmacists are forced to withdraw from the program, pressure will fall on already-overworked GPs and other primary care providers to deliver – causing patients to delay their vaccination.

“As a nation that is on the verge of more widely opening up to domestic and international travel, we simply cannot afford to drop the ball on this.

“We need to support our frontline pharmacists so they can continue to support the Australian community,” A/Prof Freeman said.

Pharmacists receive a flat $16 for administering a booster vaccine, whilst GPs may be able to claim additional dose administration ($24.45), and a suitability assessment ($39.10) for a total of $63.55. This is higher for GP’s in rural areas and after hours.

No after-hours payments are available for pharmacists despite many providing access outside of normal business hours.

If all three doses and a COVID-19 Vaccine Suitability Assessment are provided by the same practitioner, in a major city, a pharmacist would receive $58, whilst a GP would receive $129.05.

Human Resources

New gender pay gap data highlights disproportionate impact of inflation on Australian women

Health Industry Hub | August 19, 2022 |

Human Resources: Men are earning an average of $263.90 more than women a week, according to the latest gender pay gap data. […]


News & Trends - Medical Technology

MedTech News -

MedTech partnership to support brain and spine therapy in Asia Pacific region

Health Industry Hub | August 19, 2022 |

MedTech News: A new medtech partnership will support specialist physicians from across the Asia-Pacific region and pioneer new precision approaches […]


News & Trends - Pharmaceuticals

Consumer Health Forum and Patient Voice Initiative join Medicines Australia in voicing priorities for NMP Review restart

Health Industry Hub | August 19, 2022 |

Pharma News: Medicines Australia welcomes the restart of the National Medicines Policy (NMP) Review, which was put on hold prior […]


News & Trends - Pharmaceuticals

First public hospital to launch e-prescriptions in changing the dynamics of how patients access medicines

Health Industry Hub | August 19, 2022 |

Pharma News: In a first for public hospitals nationally, patients at Royal Perth Hospital can now obtain electronic prescriptions that […]


This content is copyright protected